Executive Summary
The Delhi High Court, in a series of connected appeals, addressed challenges to an earlier finding regarding trademark non-use. While some applications were disposed of with exemptions allowed, the court granted a stay on the main impugned judgment. This decision highlights the ongoing judicial scrutiny over trademark cancellation proceedings, particularly when conflicting interpretations of Supreme Court precedents arise.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Thukral Mechanical Works vs Pm Diesels Private Limited & Anr. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Janssen Pharmaceuticals & OthersvsMSN Laboratories Pvt. Ltd.
Plaintiffs, exclusive licensees of a patent holder (Mitsubishi Tanabe Pharma Corporation), filed suit alleging that Defendant No. 1 was manufacturing and marketing Canagliflozin Tablets/Capsules, which falls under Indian Patent No. 232231. The defendant opposed the interim injunction, arguing that damages could be quantified and there was no irreparable loss. The court found a prima facie case in favor of the plaintiffs.
Jaskaran SinghvsFlipkart Internet Private Limited
The Delhi High Court addressed an appeal filed by Jaskaran Singh against Flipkart regarding alleged trademark infringement and counterfeiting of goods under the 'ANMEX' brand. The appellant sought an interim injunction to stop unauthorized third parties from selling counterfeit goods on the platform. While acknowledging the severity of the issue, the court disposed of the appeal with a crucial direction: Flipkart must provide the names, addresses, and email IDs of the alleged infringing 'more sellers/latch on sellers' within one week. This move allows the litigation to proceed by identifying the specific parties responsible for the infringement.
Alkem Laboratories Ltd.vsHealing Pharma India Pvt. Ltd. & Anr.
The Delhi High Court addressed an infringement suit filed by Alkem Laboratories against Healing Pharma India. The plaintiff alleged that the defendant's trademark and trade dress were deceptively similar, specifically mimicking the plaintiff's 'rising sun' motif. While the court allowed procedural applications for document filing and curing deficiencies, it also moved forward with the litigation by ordering summons to be issued in the main suit.
Mylan Laboratories LimitedvsUnion Of India & Ors
Mylan Laboratories Limited challenged an order that granted a patent for 'Methods of Evaluating Peptide Mixtures' after dismissing their pre-grant opposition. The petitioner sought urgent relief as the Intellectual Property Appellate Board (IPAB) was non-functional due to long-standing vacancies in its Technical Member positions, leading to a logjam of appeals. The Delhi High Court addressed this systemic issue by invoking the doctrine of necessity, ruling that IPAB can continue hearing urgent matters related to Patents, Trademarks, and Copyrights even with vacant technical posts.
Eris Lifesciences LimitedvsController Of Patents & Anr.
Both petitions sought the revocation of Indian Patent No. 243301 under Section 64 of The Patents Act, 1970. The court condoned delays in filing written statements and disposed of related interlocutory applications. The matter was listed for further hearing due to the patent's impending expiry.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.